Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1.37 USD
Change Today -0.05 / -3.52%
Volume 664.6K
AVEO On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert C. Young M.D.

Director, Chairman of Nominating & Governance Committee and Member of Audit Committee,AVEO Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 12 board members in 1 different organizations across 3 different industries.

See Board Relationships
75$61,122

Background*

Mr. Robert C. Young, M.D. serves as the President of RCY Medicine. Mr. Young served as Chancellor of Fox Chase Cancer Center in Philadelphia. Dr. Young served as President of Fox Chase Cancer Center from 1988 to 2007 and served as its Chief Executive Officer. From 1974 to 1988, he served at the National Cancer Institute as Chief, Medical Branch. Dr. Young served as the President of the American Society of Clinical Oncology (ASCO), the American Cancer Society and the ...

Read Full Background

Corporate Headquarters*

650 East Kendall Street
Cambridge, Massachusetts 02142

United States

Phone: 617-299-5000
Fax: --

Board Members Memberships*

2009-Present
Director, Chairman of Nominating & Governance Committee and Member of Audit Committee

Education*

BS
The Ohio State University
MD
Weill Cornell Medical College, New York

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$48,683
Total Calculated Compensation$61,122
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AVEO:US $1.37 USD -0.05

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Paolo Pucci Chief Executive Officer and Director
ArQule Inc.
$489.3K
Giovanni Caforio M.D.Chief Executive Officer and Director
Bristol-Myers Squibb Company
$916.0K
Michael M. Morrissey Ph.D.Chief Executive Officer, President and Director
Exelixis, Inc.
$755.2K
Christophe Weber Chief Executive Officer, President and Representative Director
Takeda Pharmaceutical Company Limited
¥230.0M
Andrew Philip Witty Chief Executive Officer, Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline S.A.E
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AVEO PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.